In mid-2023, the European Medicines Agency (EMA) announced it was reviewing safety data on GLP-1 drugs after receiving post-marketing reports of depression and self-harm in patients on these medications
Serving McKinney & Surrounding Communities Medrocs Pharmacy provides compounded GLP1 medications, including semaglutide and tirzepatide, to patients in McKinney, Allen, Frisco, Prosper, and Plano
### Should I take semaglutide or tirzepatide in the morning or at night
Research on NAD+ supplementation, usually through precursors like NMN or NR, suggests potential benefits for anti-aging and cellular health
Doctors often base their recommendation on the patient's overall health, co-existing conditions, and potential side effect management
Accessed May 9, 2024 .] Approved for weight loss in November 2023 under the name Zepbound, tirzepatide was approved as the diabetes drug Mounjaro in 2022